Related Experiment Video
Updated: Aug 11, 2026
06:31
Erosion Identification in Metacarpophalangeal Joints in Rheumatoid Arthritis using High-Resolution Peripheral Quantitative Computed Tomography
Published on: October 6, 2023
Exploring the Association Between Rheumatoid Arthritis and Parkinson's Disease: Evidence from 2001-2016 NHANES,
Yan Cheng1, Yunzhou Yang1, Yong Liu1
1Department of Neurology, Lu'an Hospital of Anhui Medical University, Lu'an, 237000, People's Republic of China.
Journal of Inflammation Research
|August 10, 2026
Summary
Rheumatoid arthritis (RA) is linked to a higher risk of Parkinson's disease (PD). Key genes like GNB2L1, HSPA9, and RPA1 may be involved in common molecular pathways, offering potential therapeutic targets for both conditions.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Parkinson's disease (PD) and rheumatoid arthritis (RA) are prevalent chronic conditions with unknown links.
- Investigating shared molecular mechanisms between PD and RA is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To explore the potential association between RA and PD.
- To identify common genetic signatures and molecular pathways linking RA and PD.
Main Methods:
- Utilized logistic regression analysis on NHANES and clinical data to assess RA-PD association.
- Employed transcriptomic data analysis to identify common differentially expressed genes (DEGs) and regulatory networks.
- Applied Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) to explore pathway involvement.
Main Results:
- Confirmed a significant association between RA and an increased risk of PD.
- Identified 79 common DEGs, including key genes GNB2L1, HSPA9, and RPA1.
- Highlighted immune response, T cell receptor, and PI3K-Akt signaling pathways as commonly enriched. Identified MTORC1_SIGNALING, OXIDATIVE_PHOSPHORYLATION, and MYC_TARGETS_V1 as key regulatory pathways.
- Constructed a nomogram model with favorable predictive performance for both diseases.
Conclusions:
- Established a significant association between PD and RA.
- GNB2L1, HSPA9, and RPA1 are implicated in the complex regulatory mechanisms of both PD and RA.
- Findings provide novel insights into shared molecular underpinnings and potential therapeutic targets for PD and RA, warranting further experimental validation.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...